Wird geladen...
Efavirenz Therapeutic Range in HIV-1 Treatment Naïve Participants
OBJECTIVES: Efavirenz is currently suggested as an alternative to recommended antiretroviral (ARV) regimens by the Department of Health and Human Services for the treatment of HIV-1 in ARV-naive patients. A mid-dosing interval therapeutic range between 1,000 and 4,000 ng/mL for efavirenz has been pr...
Gespeichert in:
| Veröffentlicht in: | Ther Drug Monit |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
2017
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5718358/ https://ncbi.nlm.nih.gov/pubmed/29135907 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FTD.0000000000000443 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|